M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3

Experimental and Molecular Pathology

Volumn 96, Issue 3, 2014, Pages 382-392

  Wijesundera, Kavindra Kumara ^a   Izawa, Takeshi ^a   Tennakoon, Anusha Hemamali ^a   Murakami, Hiroshi ^a   Golbar, Hossain M ^a   Katou Ichikawa, Chisa ^a   Tanaka, Miyuu ^a   Kuwamura, Mitsuru ^a   Yamate, Jyoji ^a  

^a Osaka City University   (Japan)

Author keywords

Cirrhosis; Galectin 3; Iba1; Macrophage polarization; Thioacetamide

Indexed keywords

CALCIUM BINDING PROTEIN; CD163 ANTIGEN; CD204 ANTIGEN; CD68 ANTIGEN; GALECTIN 3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN IBA1; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIVER CIRRHOSIS; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; POLARIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CIRRHOSIS; GALECTIN-3; IBA1; MACROPHAGE POLARIZATION; THIOACETAMIDE;

ANIMALS; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CHEMOKINE CCL2; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MALE; MICROFILAMENT PROTEINS; MYOFIBROBLASTS; RATS; RATS, INBRED F344; RNA, MESSENGER; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84899847259     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.04.003     Document Type: Article

References (73)

1. Ajmone-Cat M.A., Mancini M., De Simone R., Cilli P., Minghetti L. Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures. Glia 2013, 61:1698-1711.
2. Barondes S.H., Cooper D.N., Gitt M.A., Leffler H. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 1994, 269:20807-20810.
3. Chang J., Hisamatsu T., Shimamura K., Yoneno K., Adachi M., Naruse H., Igarashi T., Higuchi H., Matsuoka K., Kitazume M.T., Ando S., Kamada N., Kanai T., Hibi T. Activated hepatic stellate cells mediate the differentiation of macrophages. Hepatol. Res. 2013, 43:658-669.
4. Chen S., Wang H.T., Yang B., Fu Y.R., Ou Q.J. Protective effects of recombinant human growth hormone on cirrhotic rats. World J. Gastroenterol. 2004, 10:2894-2897.
5. Chilakapati J., Shankar K., Korrapati M.C., Hill R.A., Mehendale H.M. Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab. Dispos. 2005, 33:1877-1885.
6. Connolly M.K., Bedrosian A.S., Mallen-St Clair J., Mitchell A.P., Ibrahim J., Stroud A., Pachter H.L., Bar-Sagi D., Frey A.B., Miller G. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 2009, 119:3213-3225.
7. Conrad A.T., Dittel B.N. Taming of macrophage and microglial cell activation by microRNA-124. Cell Res. 2011, 21:213-216.
8. Damoiseaux J.G., Döpp E.A., Calame W., Chao D., MacPherson G.G., Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994, 83:140-147.
9. Dasgupta S., Bhattacharya-Chatterjee M., O'Malley B.W., Chatterjee S.K. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer. J. Immunol. 2005, 175:5541-5550.
10. Dong S., Hughes R.C. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj. J. 1997, 14:267-274.
11. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
12. Fabriek B.O., Dijkstra C.D., van den Berg T.K. The macrophage scavenger receptor CD163. Immunobiology 2005, 210:153-160.
13. Fainboim L., Cherñavsky A., Paladino N., Flores A.C., Arruvito L. Cytokines and chronic liver disease. Cytokine Growth Factor Rev. 2007, 18:143-157.
14. Friedman S.L. Hepatic fibrosis - overview. Toxicology 2008, 254:120-129.
15. Fu Y., Zheng S., Lin J., Ryerse J., Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol. Pharmacol. 2008, 73:399-409.
16. Fujisawa K., Miyoshi T., Tonomura Y., Izawa T., Kuwamura M., Torii M., Yamate J. Relationship of heat shock protein 25 with reactive macrophages in thioacetamide-induced rat liver injury. Exp. Toxicol. Pathol. 2011, 63:599-605.
17. Gao B., Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim. Biophys. Acta 2013, 1832:1061-1069.
18. George S.L., Bacon B.R., Brunt E.M., Mihindukulasuriya K.L., Hoffmann J., Di Bisceglie A.M. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2009, 49:729-738.
19. Glässner A., Eisenhardt M., Kokordelis P., Krämer B., Wolter F., Nischalke H.D., Boesecke C., Sauerbruch T., Rockstroh J.K., Spengler U., Nattermann J. Impaired CD4(+) T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. J. Hepatol. 2013, 59:427-433.
20. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
21. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
22. Gratchev A., Kzhyshkowska J., Köthe K., Muller-Molinet I., Kannookadan S., Utikal J., Goerdt S. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006, 211:473-486.
23. Hara M., Kono H., Furuya S., Hirayama K., Tsuchiya M., Fujii H. Macrophage colony-stimulating factor plays a pivotal role in chemically induced hepatocellular carcinoma in mice. Hepatol. Res. 2013, (Epub ahead of print). 10.1111/hepr.12174.
24. Henderson N.C., Mackinnon A.C., Farnworth S.L., Poirier F., Russo F.P., Iredale J.P., Haslett C., Simpson K.J., Sethi T. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5060-5065.
25. Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011, 6:425-456.
26. Hintermann E., Bayer M., Pfeilschifter J.M., Luster A.D., Christen U. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation. J. Autoimmun. 2010, 35:424-435.
27. Holt A.P., Salmon M., Buckley C.D., Adams D.H. Immune interactions in hepatic fibrosis. Clin. Liver Dis. 2008, 12:861-882.
28. Hu W., Jiang Z., Zhang Y., Liu Q., Fan J., Luo N., Dong X., Yu X. Characterization of infiltrating macrophages in high glucose-induced peritoneal fibrosis in rats. Mol. Med. Rep. 2012, 6:93-99.
29. Ide M., Yamate J., Machida Y., Sawamoto O., Nakanishi M., Kuwamura M., Kotani T. Macrophage populations, myofibroblastic cells, and extracellular matrix accumulation in chronically-developing rat liver cirrhosis induced by repeated injection of thioacetamide. J. Toxicol. Pathol. 2002, 15:19-29.
30. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 2007, 117:539-548.
31. Iredale J.P., Thompson A., Henderson N.C. Extracellular matrix degradation in liver fibrosis: biochemistry and regulation. Biochim. Biophys. Acta 2013, 1832:876-883.
32. Ishihara K., Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim. Biophys. Acta 2002, 1592:281-296.
33. Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 1998, 57:1-9.
34. Ito D., Tanaka K., Suzuki S., Dembo T., Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001, 32:1208-1215.
35. Jeong W.I., Park O., Suh Y.G., Byun J.S., Park S.Y., Choi E., Kim J.K., Ko H., Wang H., Miller A.M., Gao B. Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice. Hepatology 2011, 53:1342-1351.
36. Kaneko T., Okiji T., Zhao L., Esgeurra R., Suda H. Heterogeneity of dendritic cells in rat apical periodontitis. Cell Tissue Res. 2008, 331:617-623.
37. Kitazawa T., Nakatani Y., Fujimoto M., Tamura N., Uemura M., Fukui H. The production of tumor necrosis factor-alpha by macrophages in rats with acute alcohol loading. Alcohol. Clin. Exp. Res. 2003, 27:72S-75S.
38. Kiyanagi T., Iwabuchi K., Shimada K., Hirose K., Miyazaki T., Sumiyoshi K., Iwahara C., Nakayama H., Masuda H., Mokuno H., Sato S., Daida H. Involvement of cholesterol-enriched microdomains in class A scavenger receptor-mediated responses in human macrophages. Atherosclerosis 2011, 215:60-69.
39. Mantovani A., Locati M. Orchestration of macrophage polarization. Blood 2009, 114:3135-3136.
40. Martinez F.O. Regulators of macrophage activation. Eur. J. Immunol. 2011, 41:1531-1534.
41. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
42. Meghari S., Berruyer C., Lepidi H., Galland F., Naquet P., Mege J.L. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. Eur. J. Immunol. 2007, 37:24-32.
43. Meindl-Beinker N.M., Dooley S. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J. Gastroenterol. Hepatol. 2008, 23:122-127.
44. Mori Y., Izawa T., Takenaka S., Kuwamura M., Yamate J. Participation of functionally different macrophage populations and monocyte chemoattractant protein-1 in early stages of thioacetamide-induced rat hepatic injury. Toxicol. Pathol. 2009, 37:463-473.
45. Muriel P., Escobar Y. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. J. Appl. Toxicol. 2003, 23:103-108.
46. Njoku D.B., Li Z., Washington N.D., Mellerson J.L., Talor M.V., Sharma R., Rose N.R. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury. Eur. J. Immunol. 2009, 39:1652-1663.
47. Ohsawa K., Imai Y., Kanazawa H., Sasaki Y., Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell Sci. 2000, 113:3073-3084.
48. Orr G.A., Chrisler W.B., Cassens K.J., Tan R., Tarasevich B.J., Markillie L.M., Zangar R.C., Thrall B.D. Cellular recognition and trafficking of amorphous silica nanoparticles by macrophage scavenger receptor A. Nanotoxicology 2011, 5:296-311.
49. Otto C., Heeg A., Kottenmeier S., Tiurbe G.C., Thiede A., Ulrichs K. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties. Transplant. Proc. 2006, 38:755-756.
50. Pello O.M., Silvestre C., De Pizzol M., Andrés V. A glimpse on the phenomenon of macrophage polarization during atherosclerosis. Immunobiology 2011, 216:1172-1176.
51. + T cell interactions promote T(H)2 cytokine-dependent immunity. Nat. Immunol. 2009, 10:697-705.
52. Ploeger D.T., Hosper N.A., Schipper M., Koerts J.A., de Rond S., Bank R.A. Cell plasticity in wound healing: paracrine factors of M1/M2 polarized macrophages influence the phenotypical state of dermal fibroblasts. Cell Commun. Signal. 2013, 11:29.
53. Polfliet M.M.J., Fabriek B.O., Daniëls W.P., Dijkstra C.D., van den Berg T.K. The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology 2006, 211:419-425.
54. Pradere J.P., Kluwe J., De Minicis S., Jiao J.J., Gwak G.Y., Dapito D.H., Jang M.K., Guenther N.D., Mederacke I., Friedman R., Dragomir A.C., Aloman C., Schwabe R.F. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 2013, 58:1461-1473.
55. Ramachandran P., Pellicoro A., Vernon M.A., Boulter L., Aucott R.L., Ali A., Hartland S.N., Snowdon V.K., Cappon A., Gordon-Walker T.T., Williams M.J., Dunbar D.R., Manning J.R., van Rooijen N., Fallowfield J.A., Forbes S.J., Iredale J.P. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3186-E3195.
56. Ruas L.P., Bernardes E.S., Fermino M.L., de Oliveira L.L., Hsu D.K., Liu F.T., Chammas R., Roque-Barreira M.C. Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS ONE 2009, 4:e4519.
57. Satoh N., Shimatsu A., Himeno A., Sasaki Y., Yamakage H., Yamada K., Suganami T., Ogawa Y. Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010, 33:e7.
58. Seki E., Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 2012, 590:447-458.
59. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
60. Sica A., Invernizzi P., Mantovani A. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology 2013, (Epub ahead of print). 10.1002/hep.26754.
61. Snelgrove S.L., Kausman J.Y., Lo C., Lo C., Ooi J.D., Coates P.T., Hickey M.J., Holdsworth S.R., Kurts C., Engel D.R., Kitching A.R. Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosis. Am. J. Pathol. 2012, 180:91-103.
62. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287-292.
63. Takahashi K., Naito M., Takeya M. Development and heterogeneity of macrophages and their related cells through their differentiation pathways. Pathol. Int. 1996, 46:473-485.
64. Thirunavukkarasu C., Watkins S.C., Gandhi C.R. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology 2006, 44:389-398.
65. Tian Y., Kelemen S.E., Autieri M.V. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am. J. Physiol. Cell Physiol. 2006, 290:C1083-C1091.
66. Volarevic V., Milovanovic M., Ljujic B., Pejnovic N., Arsenijevic N., Nilsson U., Leffler H., Lukic M.L. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 2012, 55:1954-1964.
67. Watano K., Iwabuchi K., Fujii S., Ishimori N., Mitsuhashi S., Ato M., Kitabatake A., Onoé K. Allograft inflammatory factor-1 augments production of interleukin-6, -10 and -12 by a mouse macrophage line. Immunology 2001, 104:307-316.
68. Wijesundera K.K., Juniantito V., Golbar H.M., Fujisawa K., Tanaka M., Ichikawa C., Izawa T., Kuwamura M., Yamate J. Expressions of Iba1 and galectin-3 (Gal-3) in thioacetamide (TAA)-induced acute rat liver lesions. Exp. Toxicol. Pathol. 2013, 65:799-808.
69. Wijesundera K.K., Izawa T., Murakami H., Tennakoon A.H., Golbar H.M., Kato-Ichikawa C., Tanaka M., Kuwamura M., Yamate J. M1- and M2-macrophage polarization in thioacetamide (TAA)-induced rat liver lesions; a possible analysis for hepato-pathology. Histol. Histopathol. 2014, 29:497-511.
70. Wójcik M., Ramadori P., Blaschke M., Sultan S., Khan S., Malik I.A., Naz N., Martius G., Ramadori G., Schultze F.C. Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem. Cell Biol. 2012, 137:217-233.
71. Yamate J., Sato K., Ide M., Nakanishi M., Kuwamura M., Sakuma S., Nakatsuji S. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet. Pathol. 2002, 39:322-333.
72. Yang Z.F., Ho D.W., Lau C.K., Lam C.T., Lum C.T., Poon R.T.P., Fan S.T. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int. Immunol. 2005, 17:1391-1397.
73. Yi H.S., Jeong W.I. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?. J. Gastroenterol. Hepatol. 2013, 28:99-104.